Tag: RNA-targeted Therapies
Novo Nordisk to acquire Cardior Pharmaceuticals to expand cardiovascular portfolio
In a significant move within the pharmaceutical industry, Novo Nordisk has agreed to acquire Cardior Pharmaceuticals for up to 1.025 billion Euros. This strategic acquisition ... Read More